| pubmed-article:8583625 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8583625 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:8583625 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:8583625 | lifeskim:mentions | umls-concept:C0011501 | lld:lifeskim |
| pubmed-article:8583625 | lifeskim:mentions | umls-concept:C0311400 | lld:lifeskim |
| pubmed-article:8583625 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:8583625 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8583625 | pubmed:dateCreated | 1996-3-19 | lld:pubmed |
| pubmed-article:8583625 | pubmed:abstractText | We evaluated positron emission tomograph (PET) with 18fluorine (18F)-labeled deoxyglucose for metabolic grading of untreated primary prostate cancer, and differentiation of benign and malignant prostatic disease. | lld:pubmed |
| pubmed-article:8583625 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8583625 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8583625 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8583625 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8583625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8583625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8583625 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8583625 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8583625 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:8583625 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:JakseGG | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:WolfeJ FJF | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:BüllUU | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:HandsRR | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:EffertP JPJ | lld:pubmed |
| pubmed-article:8583625 | pubmed:author | pubmed-author:BaresRR | lld:pubmed |
| pubmed-article:8583625 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8583625 | pubmed:volume | 155 | lld:pubmed |
| pubmed-article:8583625 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8583625 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8583625 | pubmed:pagination | 994-8 | lld:pubmed |
| pubmed-article:8583625 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:meshHeading | pubmed-meshheading:8583625-... | lld:pubmed |
| pubmed-article:8583625 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8583625 | pubmed:articleTitle | Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. | lld:pubmed |
| pubmed-article:8583625 | pubmed:affiliation | Department of Urology, RWTH University of Aachen, Germany. | lld:pubmed |
| pubmed-article:8583625 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8583625 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8583625 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8583625 | lld:pubmed |
